In this Q&A, Herbert Temmes, President of the European Multiple Sclerosis Platform (EMSP), shares why prevention is such a crucial and timely topic, how the MS community can be more involved in shaping decisions, and what outcomes he hopes the conference will deliver for years to come.
Amyotrophic Lateral Sclerosis: A Review of Aetiopathogenetic Insights
In this review, the authors explore the complex molecular landscape of the disease, highlighting the convergence of multiple pathogenetic pathways that complicate both its investigation and clinical management.
New coalition calls for urgent action to address rising stroke crisis
The world’s first multisector advocacy movement dedicated to stroke – the Global Stroke Action Coalition – has issued an urgent call to action to address growing inequities in stroke.
Prevention in focus: A Q&A with Herbert Temmes, EMSP President, ahead of the EMSP 2025 Annual Conference
Supporting Brain Awareness Week 2025: Advancing knowledge in brain science
touchNEUROLOGY was proud to support Brain Awareness Week 2025.
Up Next
2 of 4
Speciality Filter
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
Mark CompleteCompleted
BookmarkBookmarked
Amyotrophic lateral sclerosis (ALS) is characterized by the degeneration of both upper and lower motor neurons, which ultimately leads to muscle weakness, atrophy, spasticity and contractures.1 ALS typically manifests in the 50–60 years age range, although familial cases may present in ...
Mark CompleteCompleted
BookmarkBookmarked
The prevalence of unruptured intracranial aneurysms (IAs) is approximately 3% of the population, with incidence on the rise due to the increased utilization of neuro-imaging for diverse objectives.1,2 The average risk of rupture for unruptured IA is estimated to vary from 0.3% ...
Mark CompleteCompleted
BookmarkBookmarked
Seizures are one of the most frequent neurological disorders in neonates − the incidence of seizures in infants born at term is 1–3 per 1,000 live births, and is even higher in both preterm and very-low-birth-weight infants at 1–13 per 1,000 live births.1 Seizures may ...
Want to be featured in touchReviews in Neurology?
Share your knowledge, influence clinical practices and enhance patient care in Neurology today!
- Peer-reviewed, free-to-access
- Accepting reviews, research and editorials
- No article processing fees
- Digital features and plain language summaries
- Multichannel content distribution for maximum visibility
Mark CompleteCompleted
BookmarkBookmarked
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare, autoimmune neurological disorder in which peripheral nerve demyelination typically results in weakness, impaired limb sensation, fatigue and pain.1–4 CIDP may adversely affect activities of daily living, with a substantial impact on functional ...
Mark CompleteCompleted
BookmarkBookmarked
Huntington’s disease (HD) is a neurodegenerative disease inherited in an autosomal dominant manner. It is caused by an expansion of cytosine, adenine, guanine (CAG) repeats within the huntingtin (HTT) gene, which is located on chromosome 4. This pathological expansion of ...
touchVisionary Voices
Mark CompleteCompleted
BookmarkBookmarked
In this episode, we’re joined by Bradley Love, Professor of Cognitive and Decision Sciences at UCL, ELLIS fellow, and creator of BrainGPT. We discuss how this large language model is poised to assist researchers in advancing their work.
Mark CompleteCompleted
BookmarkBookmarked
Welcome to this issue of touchREVIEWS in Neurology, where we explore significant advances in neurology, cognitive health, and wearable technology in the management of various chronic conditions. This issue brings together a collection of expert perspectives and research that spans ...
Mark CompleteCompleted
BookmarkBookmarked
Cognitive impairment is the hallmark symptom of Alzheimer’s disease (AD); however, neuropsychiatric symptoms (NPS), including psychosis, agitation and mood disturbances, are common not only in AD but also in Parkinson’s disease, dementia with Lewy bodies, frontotemporal dementia and ...
Mark CompleteCompleted
BookmarkBookmarked
Diabetic striatopathy (DS) is a rare hyperglycaemic condition associated with one or both of the following criteria: (1) acute-onset chorea–ballism (random, flowing and nonsuppressible involuntary movements) and (2) striatal hyperdensity on computed tomography (CT) scan or T1-weighted magnetic resonance imaging (...
Mark CompleteCompleted
BookmarkBookmarked
Article highlights Multiple screening tests are available to screen patients for cognitive impairment, and the Confusion Assessment Method is a helpful test to screen for delirium in the immediate postoperative period. Medicine reconciliation and identification and removal of potentially inappropriate ...
Mark CompleteCompleted
BookmarkBookmarked
Parkinson’s disease (PD) is a complex neurodegenerative condition that predominantly affects older people, with a rising prevalence worldwide.1,2 There are many on-going challenges and unmet needs in PD: difficulties in making an accurate diagnosis (particularly in the early stages ...
Mark CompleteCompleted
BookmarkBookmarked
What is the Stroke Action Plan for Europe? Stroke is one of the most enormous burdens to healthcare services.1 Despite our combined efforts, it affects more than one million people annually in Europe. Although we have abundant knowledge regarding stroke ...
Mark CompleteCompleted
BookmarkBookmarked
Welcome to the latest edition of touchREVIEWS in Neurology. We are excited to present a collection of articles that showcase the latest advancements and diverse perspectives in neurological research and treatment. This issue features insightful reviews and editorials from esteemed ...
Mark CompleteCompleted
BookmarkBookmarked
Neuromyelitis optica spectrum disorders (NMOSD) are a group of relapsing autoimmune diseases of the central nervous system. The clinical hallmarks of NMOSD are myelitis and optic neuritis; however, a wider clinical spectrum has been recognized.1 The majority of patients with ...
Mark CompleteCompleted
BookmarkBookmarked
Affecting over 70 million patients worldwide, epilepsy is a chronic neurological disorder characterized by intermittent bursts of hyper-synchronous neuronal discharges.1 The manifestations are variable but reflective of the unique milieu and biology of epileptogenic foci.2 Pharmacological treatment with antiepileptic drugs (AEDs) ...
Sponsored Content
touchMEETING HIGHLIGHTS
For HCPs in: Spain, Finland, Denmark and Italy
Sanofi at ECTRIMS 2024. Join MS experts as they examine disability accumulation through the lens of personalised care, biomarkers, and clinical trial design. Hear their perspectives on the complexities of balancing improved relapse management with the ongoing challenge of disability accumulation.
Editorial Board
Introducing the Editorial Board of touchREVIEWS in Neurology, who support our mission to advance medical knowledge and practice by ensuring the integrity, relevance, and impact of the content we publish. Together, we strive to foster a vibrant academic community and contribute to the continuous improvement of healthcare worldwide.
Cris Constantinescu
Editor-in-Chief
Multiple sclerosis
Biography
Prof. Cris S Constantinescu is the co-Editor-in-Chief of touchREVIEWS in Neurology. Cris Constantinescu is Attending Neurologist at Cooper University Hospital, Cooper Neurological Institute, Cherry Hill, NJ, USA, Professor of Neurology at Cooper Medical School of Rowan University, Camden, NJ, USA, and Emeritus Professor of Neurology in the Academic Unit of Mental Health and Clinical Neurosciences at the University of Nottingham, Nottingham, UK. He graduated with an MD from Boston University School of Medicine, USA, in 1988. As a recipient of the physician-scientist award from the National Institutes of Health, USA, he completed a PhD in immunology at the University of Pennsylvania in 1998. He has completed an internship and a residency in neurology and fellowships in neuroimmunology and neurorehabilitation. He was appointed honorary consultant neurologist and senior lecturer in neurology at the University of Nottingham 2000–2001. In 2004, he was appointed Professor of Neurology and Chair in Neurology at the University of Nottingham, a post he held until 2021. He has authored or co-authored over 200 articles in international journals. His research interests are immune regulation in inflammatory diseases of the nervous system, in particular multiple sclerosis, neuroimaging, clinical trials and cognitive neurology. He is currently involved in the care of numerous patients with neuroimmunological and neurodegenerative diseases.
Said Beydoun
Editor-in-Chief
Said Beydoun
Editor-in-Chief
Neuromuscular diseases
Biography
Said R Beydoun, MD, FAAN, is Professor and Division Chief for Neuromuscular Medicine at the Department of Neurology at Keck School of Medicine, University of Southern California (USC). He is Program Director of the Clinical Neurophysiology Fellowship. As a principal investigator, Dr Beydoun has participated in multiple research clinical trials. His clinical and research areas of expertise in the field of neuromuscular medicine include amyotrophic lateral sclerosis (ALS), myasthenia gravis, peripheral neuropathy (including chronic inflammatory demyelinating polyneuropathy), multifocal motor neuropathy and transthyretin-related amyloid neuropathy. He has published in several scientific journals on topics related to neuromuscular diseases and is co-Editor-in-Chief of touchREVIEWS in Neurology. He is an elected fellow of the American Academy of Neurology and a fellow of the American Association of Neuromuscular and Electrodiagnostic Medicine; a member of the medical/scientific advisory board of the Myasthenia Gravis Foundation of America; Medical Director of the Certified ALS Treatment Center of Excellence at Keck USC; and holds board certification by the American Board of Psychiatry and Neurology in neurology, clinical neurophysiology, neuromuscular medicine and pain medicine.
Cris Constantinescu
Editor-in-Chief
K. Ray Chaudhuri
Section editor
K. Ray Chaudhuri
Section editor
Movement disorders
Biography
Prof. K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is Chairman of the Industry Engagement Committee, and Co Chair Task force of the Parkinson Wellness committee of the Movement Disorders Society (MDS and Ex Chair Membership and Public Relations Committee of the Movement Disorders Society (MDS), was a member of the MDS Congress Scientific Programme Committee (2013-2017) and is Founder and Ex Chairman and current steering group member of the MDS Non-Motor Parkinson’s Disease Study Group and a member of the MDS-ES Education committee and Evidence Based Medicine committee (Nonmotor symptoms). He was the founder -Editor-in-Chief of the njp Parkinson’s Disease (2020 impact factor >8), Guest Editor for special editions of Frontiers in Neurology and Journal of Parkinson’s Disease, reviewer for all mainstream movement disorders journals as well as JAMA, Neurology, Annals of Neurology, BMJ, Brain, Lancet, and Journal of Neurology, Neurosurgery, and Psychiatry. He serves as an advisor (MHRA health technology and scientific advisor) to the UK National Institute for Health and Care Excellence, NHS England, General Medical Council as well as Parkinson’s UK and Parkinson’s Europe.
Prof. Chaudhuri is the author of over 500 articles, co-editor of 5 books on Parkinson’s disease and restless legs syndrome, and winner of the British Medical Association Book Awards commendation in 2015 and 2017. He is also the recipient of 2018 Jay Van Andel Award Outstanding Achievement in Parkinson’s Disease Research (pioneering holistic assessments and non-motor subtypes), as well as National Institute for Health Research/Royal College of Physicians award for outstanding research leadership in 2017. He was elected honorary member of the Movement Disorders Society in 2021, Honorary Professor Brasov University, Honorary Professor SRM University, India and received the UK NHS Gold merit award in 2021 for excellence in research and clinical service. In 2023 he was featured as “role model” in British Medical Journal. He has been a guest lecturer worldwide, including in Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, the US, Russia, and Europe. In 2022/2023 he is ranked fourth in the world for Parkinson’s publications/expertise and expertise since 2014 and no 1 in the UK (expertscape: Parkinson’s disease). In 2024, an independent review in Frontiers journal by LI et al rated KRC as the one with most publications globally in nonmotor Parkinson’s since 2013 (Li et al , DOI 10.3389/fnagi.2024.1335550). In 2024 Prof. Chaudhuri will inaugurate the Kings Parkinson Charity dedicated to research to promote day to day care for People with Parkinson and their carers in conjunction with Sir Nicholas Mostyn, founder of the BBC endorsed Movers and Shakers expert patients group.
Said Beydoun
Editor-in-Chief
Leontino Battistin
Editorial Board Member
Leontino Battistin
Editorial Board Member
Neurodegenerative Diseases
Biography
Born in Fiume (actually Rijeka, Croatia) in 1939, graduated in Medicine at the University of Padova Medical School in 1963; Specialist in Neurology in 1967. During the years 1967-1970 he was Research Fellow at the Institute for Neurochemistry, Columbia University, New York, USA.
Full Professor of Neurology from 1980 and then Director of the Department of Neurosciences of the Medical School of the University of Padova till 2009. He was the Founder and Scientific Director of the Research Hospital for Neurorehabilitation, IRCCS San Camillo, Venice, from 2005 to 2014.
He has been member of the Executive Council of the Italian Society of Neurology and the President of the Italian Society for Parkinson’s Disease; he was a member of the Executive Committee on Extrapyramidal Disorders, chaired by Melvin Yahr, and after by Donald Calne, and of the one on Dementia of the World Federation of Neurology and, in 2009, Chairman of the Research Group for Organization and Delivery of Neurological Services; he has been elected at the WCN in London Vice-President for Europe of the World Federation of Neurology for the years 2001-2005; also, he has been the President of the European Society for Clinical Neuropharmacology during the years 2000-2008; he is a member of numerous International Scientific Societies, and Fellow of the American Academy of Neurology. He has been also a member of the Editorial Board of international journals of neuroscience and clinical neurology.
He has organized various International Congresses and Symposia on specific themes of neuroscience; he was the President of the 11th World Congress on Parkinson’s Disease that was held for the first time in Italy, Rome, in 1994, and President of the 2nd World Congress on Neurorehabilitation held in Venice, in 2002, when the World Federation on Neurorehabilitation was founded; also, he has been the Honorary President of the XXV World Congress of Neurology held in Rome, Italy, in October 2021.
He has published more than 300 papers in various international and national journals and edited ten volumes on specific arguments of neurology; his main scientific interests have always been cerebral metabolism and function especially in degenerative diseases of the nervous system, like Parkinson’s and Alzheimer’s disease, as well as in cerebrovascular diseases and in neurorehabilitation.
K. Ray Chaudhuri
Section editor
Stewart Tepper
Editorial Board member
touchNEUROLOGY
Register Now!
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
- Save your progress for video
- Keep track of your CME credits
- Add personalised learning notes
- Receive updates from course leaders and faculty
- Be the first to hear about new and exciting interactive learning opportunities
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
